Seizures
8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Nervous System Diseases
Narrower: Status Epilepticus 2
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| 30mg PRAX-628 for seizures | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bexicaserin for seizures | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cannabidiol for seizures | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
| Exogenous ketone ester for status epilepticus | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Levetiracetam for seizures | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Opakalim for seizures | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| RAP-219 for seizures | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rapid sedation for status epilepticus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.